EXPLAINER: Why Pfizer needs time to make COVID-19 treatment

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets

Related Keywords

White House ,District Of Columbia ,United States ,Paul Duffy ,Emmah Tobin ,Jeff Zients ,John Mcgrath ,Mike Mcdermott ,Joe Biden ,Raymund Razonable ,Charlotte Allerton ,Pfizer ,Science Department ,Drug Administration ,Chief Global Supply Officer Mike Mcdermott ,Mayo Clinic ,Pfizer Global ,Medicines Patent ,Associated Press Health ,Howard Hughes Medical Institute ,Covid 19 Pandemic ,Public Health ,Isease Outbreaks ,Eneral News ,Science ,Ung Disease ,Coronavirus ,Iseases And Conditions ,Infectious Diseases ,Business ,Ealth Care Industry ,Harmaceutical Manufacturing ,Medication ,Health ,Iagnosis And Treatment ,